Merck enters collaboration with Ridgeback Bio to develop antiviral candidate, EIDD-2801 to treat COVID-19

Merck enters collaboration with Ridgeback Bio to develop antiviral candidate, EIDD-2801 to treat COVID-19

Merck and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in early clinical development for the treatment of patients with COVID-19

Market | 28/05/2020 | By Darshana

FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection

FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection

Today the U.S. Food and Drug Administration took a new step to support the agency?s evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are an additional step to ensure the quality of the tests, validation of new assays, test calibration, and monitoring of assay performance

Biotechnology | 28/05/2020 | By Darshana

FDA Approves Only Drug in U.S. to Treat Severe Malaria

FDA Approves Only Drug in U.S. to Treat Severe Malaria

Today, the U.S. Food and Drug Administration approved artesunate for injection to treat severe malaria in adult and pediatric patients. Treatment of severe malaria with intravenous (IV) artesunate should always be followed by a complete treatment course of an appropriate oral antimalarial regimen

Manufacturing | 27/05/2020 | By Darshana

Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns

Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday

Consultants | 26/05/2020 | By Darshana

Glenmark Pharma to study potential Covid-19 drug combination

Glenmark Pharma to study potential Covid-19 drug combination

Glenmark Pharmaceuticals Ltd said on Tuesday it would begin a clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment

Industrial talks | 26/05/2020 | By Darshana

ICMR to present fully indigenous diagnostic platform for COVID-19

ICMR to present fully indigenous diagnostic platform for COVID-19

The Indian Council of Medical Research (ICMR) has validated a fully indigenous diagnostic platform for COVID-19 diagnosis.
<br />

Biotechnology | 25/05/2020 | By Darshana

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancer

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancer

Bayer has submitted an application for marketing authorization for its precision oncology treatment larotrectinib to the Ministry of Health, Labor and Welfare (MHLW) in Japan. Larotrectinib is an oral TRK inhibitor that has been developed specifically to treat adults and children

Industrial talks | 25/05/2020 | By Darshana

GSK Pharma to discontinue manufacture & supply of Zinetac tablets in India

GSK Pharma to discontinue manufacture & supply of Zinetac tablets in India

GlaxoSmithKline Pharmaceuticals announced that the company has decided to discontinue the manufacture and supply of Zinetac tablets, used to treat and prevent heartburn

Logistics&Distribution | 22/05/2020 | By Darshana

FDA Provides Promised Transparency for Antibody Tests

FDA Provides Promised Transparency for Antibody Tests

Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the ?notification list? of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency

Biotechnology | 22/05/2020 | By Darshana

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Roche today announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche?s nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX?).

Market | 22/05/2020 | By Darshana

Independent external council to advise Bayer?s Board of Management on consistent implementation

Independent external council to advise Bayer?s Board of Management on consistent implementation

An independent Sustainability Council will advise the Board of Management of Bayer AG and other functions within the company in all sustainability matters. The Council is a major part of the greater commitment to sustainability that Bayer announced last year

Packaging | 20/05/2020 | By Darshana

Covid-19: Pune-based drug firm to export favipiravir to 18 countries

Covid-19: Pune-based drug firm to export favipiravir to 18 countries

Pune-based pharmaceutical marketing company Brinton Pharmaceuticals is gearing up to export anti-viral drug favipiravir to 18 countries and awaiting approval from the Indian drug controller to launch the drug in India

Digitalization | 20/05/2020 | By Darshana

Cipla files ANDA for generic version of GSK's Advair Diskus to US FDA

Cipla files ANDA for generic version of GSK's Advair Diskus to US FDA

Cipla Limited announced its submission of an Abbreviated New Drug Application (ANDA) for fluticasone propionate and salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the United States Food and Drug Administration (FDA)

Logistics&Distribution | 20/05/2020 | By Darshana

Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore

Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore

Dr Lal PathLabs Limited, a leading diagnostic and related healthcare service provider posted 31% dip in net profit at Rs. 32.6 crore for the fourth quarter ended March 31, 2020 as compared to Rs. 47.4 crore in Q4 last year

Market | 19/05/2020 | By Darshana

Ayush in collaboration with CSIR to develop four formulations of traditional medicine to treat COVID-19

Ayush in collaboration with CSIR to develop four formulations of traditional medicine to treat COVID-19

The department of Ayurveda, Yoga, Unani, Shiddha and Homoeopathy (Ayush) in collaboration with Council of Scientific and Industrial Research (CSIR) is working on developing four formulations of traditional medicine to treat the novel coronavirus infections and accordingly clinical trials are also being planned within next one week

Manufacturing | 19/05/2020 | By Darshana

BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment

BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment

Bellus a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it will convene a virtual Key Opinion Leader (?KOL?) meeting to discuss the chronic cough landscape on Wednesday, May 27, 2020 at 9:00 a.m. EDT

Biotechnology | 15/05/2020 | By Darshana

FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients

FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients

Today, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements

Global Pharma | 15/05/2020 | By Darshana

Lupin Extends ?Jan Kovid? Helpline for Bhopal and Indore Citizens

Lupin Extends ?Jan Kovid? Helpline for Bhopal and Indore Citizens

Pharma major Lupin Limited (Lupin) today announced the extension of the ?Jan Kovid? Helpline (1800-572-6130) for the residents of Bhopal and Indore

Digitalization | 15/05/2020 | By Darshana

Regeneron Pharma & CCPM enter research collaboration to advance human genetics and precision medicine

Regeneron Pharma & CCPM enter research collaboration to advance human genetics and precision medicine

Regeneron PharmaceuticalsInc and the Colorado Center for Personalized Medicine (CCPM) at the University of ColoradoAnschutz Medical Campus, announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine

Safety | 13/05/2020 | By Darshana

Cipla & Jubilant sign pact with Gilead for manufacturing and distribution of remdesivir for COVID-19 treatment

Cipla & Jubilant sign pact with Gilead for manufacturing and distribution of remdesivir for COVID-19 treatment

Cipla Limited has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine remdesivir, which has been issued an Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) to treat COVID-19 patients

Manufacturing | 13/05/2020 | By Darshana

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology